EUVIMEDEUVIMED entdecken
Crossref

Adaptive designs for IVPT data with mixed scaled average bioequivalence

Daeyoung Lim iD, Elena Rantou, Jessica Kim, Sungwoo Choi, Nam Hee Choi, Stella Grosser

Pharmaceutical Statistics · 2023

DOI: 10.1002/pst.2333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2023. Verfasst von Daeyoung Lim und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Connecticut, Storrs, Connecticut, USA. Hauptthemen laut MEDLINE: Research Design, Drugs, Generic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vitro permeation tests (IVPT) offer accurate and cost‐effective development pathways for locally acting drugs, such as topical dermatological products. For assessment of bioequivalence, the FDA draft guidance on generic acyclovir 5% cream introduces a new experimental design, namely the single‐dose, multiple‐replicate per treatment group design, as IVPT pivotal study design. We examine the statistical properties of its hypothesis testing method—namely the mixed scaled average bioequivalence (MSABE). Meanwhile, some adaptive design features in clinical trials can help researchers make a decision earlier with fewer subjects or boost power, saving resources, while controlling the impact on family‐wise error rate. Therefore, we incorporate MSABE in an adaptive design combining the group sequential design and sample size re‐estimation. Simulation studies are conducted to study the passing rates of the proposed methods—both within and outside the average bioequivalence limits. We further consider modifications to the adaptive designs applied for IVPT BE trials, such as Bonferroni's adjustment and conditional power function. Finally, a case study with real data demonstrates the advantages of such adaptive methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignDrugs, GenericHumansTherapeutic EquivalencySample SizeComputer Simulation

Stichwörter der Autor:innen

adaptive designgroup sequential designin vitro permeation test (IVPT)mixed scaled average bioequivalence (MSABE)sample size re-estimation

Substanzen

Drugs, Generic

Autor:innen und Institutionen

  • University of Connecticut, Storrs, Connecticut, USA.
  • Office of Biostatistics, Office of Translational Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

ORCID-Profile: Daeyoung Lim

Zitieren

APA

Lim, D., Rantou, E., Kim, J., Choi, S., Choi, N. H., & Grosser, S. (2023). Adaptive designs for IVPT data with mixed scaled average bioequivalence. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2333

Vancouver

Lim D, Rantou E, Kim J, Choi S, Choi NH, Grosser S. Adaptive designs for IVPT data with mixed scaled average bioequivalence. Pharmaceutical Statistics. 2023. doi:10.1002/pst.2333

BibTeX
@article{Lim2023,
  author = {Lim, Daeyoung and Rantou, Elena and Kim, Jessica and Choi, Sungwoo and Choi, Nam Hee and Grosser, Stella},
  title = {Adaptive designs for IVPT data with mixed scaled average bioequivalence},
  journal = {Pharmaceutical Statistics},
  year = {2023},
  doi = {10.1002/pst.2333}
}
Kostenlos starten →